Who are LTC 15 minutes's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Hydroquinone Methyl Ether, Shade Uvaguard, Infuvite Adult, Ascaricid, Tri-luma, Arbutyne.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ltc-15-minutes.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

LTC 15 minutes — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LTC 15 minutes (LTC 15 minutes) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Skin lightening agent. Area: Dermatology.

marketed Skin lightening agent Tyrosinase Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

LTC 15 minutes (LTC 15 minutes) — Netherlands Institute for Pigment Disorders. LTC 15 minutes is a medication that works by temporarily reducing the appearance of age spots and hyperpigmentation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
LTC 15 minutes TARGET	LTC 15 minutes	Netherlands Institute for Pigment Disorders	marketed	Skin lightening agent	Tyrosinase
Hydroquinone Methyl Ether	MEQUINOL		marketed	Skin Lightening Agent	Tyrosinase	1999-01-01
Shade Uvaguard	AVOBENZONE	Bayer	marketed	avobenzone	Tyrosinase	1992-01-01
Infuvite Adult	ASCORBIC ACID		marketed	Vitamin C [EPC]	Tyrosinase	1985-01-01
Ascaricid	hexylresorcinol		marketed	hexylresorcinol	Arachidonate 5-lipoxygenase, Tyrosinase, Polyphenol oxidase 2
Tri-luma	Tri-luma	Hexsel Dermatology Clinic	marketed	Topical depigmenting agent combination	Tyrosinase; retinoic acid receptor; glucocorticoid receptor
Arbutyne	ARBUTIN		marketed	Adenosine Receptor Agonist [EPC]	Tyrosinase, Polyphenol oxidase 2, Tyrosinase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Skin lightening agent class)

Netherlands Institute for Pigment Disorders · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LTC 15 minutes — Competitive Intelligence Brief. https://druglandscape.com/ci/ltc-15-minutes. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab